Riskpilot← Back to searchSign inGet full accessMeddle Oy
OYActiveY-tunnus 3212122-9Mikontanhua 96Medical specialists activities · NACE 8622Est. 202131 employees
Revenue 2025
EUR 400K
-1% vs 2024
EBITDA margin
16.8%
-21% vs 2024
Equity ratio
67.3%
Financial strength
Net profit 2025
EUR 38K
-21% vs 2024
| Revenue | EUR 400K | -1% |
| EBITDA | EUR 67K | -21% |
| Net profit | EUR 38K | -21% |
| Total assets | EUR 275K | +6% |
| Equity | EUR 185K | +15% |
| Employees | 31 | — |
Legal name
Meddle Oy
Y-tunnus number
3212122-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
19. toukokuuta 2021
Share capital
EUR 0
Employees
31 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkäripalvelut ja muut terveyden- ja sairaanhoitopalvelut sekä edelliseen liittyen opetus- ja konsultointipalvelut. Yhtiön toimintaan kuuluu myös sijoitustoiminta, jonka tukemiseksi yhtiö voi omistaa, ostaa, myydä, hallita ja vuokrata huoneistoja, kiinteistöjä, arvopapereita, osakkeita, osuuksia, oikeuksia, irtainta ja kiinteää omaisuutta sekä kotimaassa ja ulkomailla.
Address
Mikontanhua 96
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 411 | 361 | 404 | 400 |
| Staff expenses | −225 | −195 | −219 | −232 |
| EBITDA | 107 | 82 | 85 | 67 |
| Depreciation & amort. | −0 | −27 | −20 | −15 |
| EBIT | 107 | 55 | 65 | 52 |
| Net financials | — | −0 | −6 | −5 |
| Profit before tax | 107 | 55 | 59 | 47 |
| Tax | 21 | 11 | 12 | 9 |
| Net profit | 86 | 44 | 47 | 38 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 110 | 236 | 259 | 275 |
| Equity | 86 | 123 | 160 | 185 |
| Long-term debt | — | 8 221 | 77 | 66 |
| Short-term debt | 24 | 31 | 22 | 24 |
| Total debt | 24 | 113 | 99 | 90 |
EBITDA margin
16.8%
This company
15.8%
Market median
+6% vs market
20222025
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20222025
Return on equity
20.3%
This company
18.4%
Market median
+10% vs market
20222025
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20222025
Asset turnover
1.45×
This company
1.12×
Market median
+29% vs market
20222025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-19 – 2022-10-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LL Deputy Member | Deputy Member | 2021 |
HA Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairperson | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Meddle Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laura Lotta Emilia Tervonen | Deputy Member | 0 companies |
| Harri Aulis Aspfors | Chief Executive Officer | 0 companies |
| Elli Johanna Aspfors | Chairperson | 0 companies |